Roshanak Rahimian, PharmD, MSc, PhD
MS in Pharmacology, University of Ottawa, Canada, 1995
PharmD, Tehran University of Medical Sciences, Iran, 1988
PhD in Pharmacology, University of British Columbia, Canada, 1998
At Pacific Since: 2001
Roshanak Rahimian, PharmD, MSc, PhD earned her doctor of pharmacy from Tehran University of Medical Sciences in Tehran, Iran in 1988 and her master of science from the University of Ottawa in Ottawa, Canada in 1995. Dr. Rahimian earned her doctor of philosophy from University of British Columbia in British Columbia, Canada in 1998. She then completed a three-year post doctoral fellowship from the Canadian Institute of Health Research before joining the Pacific family in 2001.
Dr. Rahimian's passion for teaching is evident in everything she does. What she loves about teaching at Pacific is the student-body and the outstanding environment for active learning. It is her goal to ensure that students learn fundamental skills in her class and laboratory. Her areas of expertise are cardiovascular and endocrine physiology, pathophysiology and pharmacology.
Her objective as a faculty member and scholar is to fully support the students while they work to achieve their goals. She serves as the Faculty Advisor for the Alpha Xi chapter of Lambda Kappa Sigma. The individual who has influenced her most in her career is her mother.
Teaching Philosophy: "As Aristotle stated, "Teaching is the highest form of understanding." I encourage students to understand fundamental concepts, think critically, and apply their knowledge to solve real-world problems in community contexts. I also view teaching as central to all of my scholarly activities."
PCSP 235 - Current topics in Pharmacology and Toxicology
PHRM 123 - Physiology and Pathophysiology II
PHRM 142 - Physiology and Pathophysiology III
PHRM 145 - Pharmacology and Medicinal Chemistry II
Research Summary: "My research focuses on estrogen-mediated signaling events associated with vascular tone and the changes that occur in diabetes (a project supported by the National Institute of Health). Diabetes mellitus affects more than 300 million persons worldwide and the number of diabetic patients is estimated to rise by more than 50% within 20 years. Cardiovascular diseases are the leading cause of mortality and morbidity in diabetic patients. The overall goal of my studies is to elucidate the cellular and molecular mechanisms responsible for the impairment of sex-based cardiovascular protection in premenopausal diabetic females."
Thor, D., Zhang, R., Anderson, L., Bose, D., Dube, G., and Rahimian, R. Effects of 17 β-estradiol on lipopolysacharride-induced intracellular adhesion molecule-1 mRNA expression and Ca2+ homeostasis alteration in human endothelial. Vascular Pharmacology (2010) 53, 230-238.
Thor, D., Uchizono, J., Lin-Cereghino, J., and Rahimian, R. The effect of 17 β-estradiol on intracellular calcium homeostasis in human endothelial cells. European journal of Pharmacology (2010) 630, 92-99.
Goel, A., Thor, D., Anderson, L., and Rahimian, R. Sexual dimorphism in rabbit aortic endothelial function under hyperglycemic conditions and gender-specific response to acute 17-beta estradiol. American Journal of Physiology- Heart Circulatory Physiology (2008) 294, H2411-2420.
Goel, A., Zhang, Y. Anderson, L., and Rahimian, R. Gender difference in rat aorta vasodilation after acute exposure to high glucose: involvement of protein kinase C β but not rho kinase. Cardiovascular Research (2007) 76, 351-60.